On May 5, 2022, Gilead Sciences, Inc. announced that at its annual general meeting of shareholder held on May 4, 2022, the Company's stockholders did not approve a stockholder proposal requesting a Board report on oversight of risks related to anticompetitive practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
65.27 USD | -2.70% | -1.35% | -19.43% |
Apr. 25 | News Highlights : Top Company News of the Day - Thursday at 5 PM ET | DJ |
Apr. 25 | News Highlights : Top Company News of the Day - Thursday at 7 PM ET | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.43% | 83.65B | |
+24.17% | 562B | |
-6.33% | 358B | |
+19.90% | 322B | |
+7.95% | 297B | |
+13.45% | 219B | |
+6.04% | 199B | |
-10.51% | 196B | |
-12.26% | 149B | |
-6.47% | 146B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- Declaration of Voting Results by Gilead Sciences, Inc